K+S Past Earnings Performance
Past criteria checks 1/6
K+S has been growing earnings at an average annual rate of 26.5%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 13.7% per year. K+S's return on equity is 0.4%, and it has net margins of 0.7%.
Key information
26.5%
Earnings growth rate
26.5%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 13.7% |
| Return on equity | 0.4% |
| Net Margin | 0.7% |
| Next Earnings Update | 13 Mar 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How K+S makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,702 | 26 | 185 | 0 |
| 30 Jun 24 | 3,717 | 4 | 181 | 0 |
| 31 Mar 24 | 3,669 | -35 | 183 | 0 |
| 31 Dec 23 | 3,873 | 210 | 184 | 0 |
| 30 Sep 23 | 4,383 | 715 | 190 | 0 |
| 30 Jun 23 | 4,972 | 1,045 | 186 | 0 |
| 31 Mar 23 | 5,656 | 1,461 | 185 | 0 |
| 31 Dec 22 | 5,677 | 1,508 | 186 | 0 |
| 30 Sep 22 | 5,262 | 1,462 | 194 | 0 |
| 30 Jun 22 | 4,538 | 2,450 | 195 | 0 |
| 31 Mar 22 | 3,692 | 2,229 | 180 | 0 |
| 31 Dec 21 | 3,213 | 2,134 | 176 | 0 |
| 30 Sep 21 | 2,772 | 1,559 | 180 | 0 |
| 30 Jun 21 | 2,592 | -1,458 | 178 | 0 |
| 31 Mar 21 | 2,518 | -1,612 | 192 | 0 |
| 31 Dec 20 | 2,432 | -1,891 | 197 | 0 |
| 30 Sep 20 | 1,306 | -1,853 | 40 | 0 |
| 30 Jun 20 | 1,645 | -163 | 100 | 0 |
| 31 Mar 20 | 1,933 | -145 | 141 | 0 |
| 31 Dec 19 | 2,550 | 27 | 172 | 0 |
| 30 Sep 19 | 4,264 | 127 | 361 | 0 |
| 30 Jun 19 | 4,199 | 121 | 344 | 0 |
| 31 Mar 19 | 4,133 | 75 | 346 | 0 |
| 31 Dec 18 | 4,039 | 42 | 350 | 0 |
| 30 Sep 18 | 3,854 | 13 | 537 | 4 |
| 30 Jun 18 | 3,740 | 89 | 641 | 8 |
| 31 Mar 18 | 3,670 | 159 | 758 | 11 |
| 31 Dec 17 | 3,627 | 185 | 936 | 17 |
| 30 Sep 17 | 3,536 | 154 | 834 | 16 |
| 30 Jun 17 | 3,497 | 113 | 858 | 16 |
| 31 Mar 17 | 3,488 | 75 | 872 | 16 |
| 31 Dec 16 | 3,457 | 174 | 871 | 14 |
| 30 Sep 16 | 3,508 | 302 | 968 | 14 |
| 30 Jun 16 | 3,712 | 380 | 989 | 14 |
| 31 Mar 16 | 3,894 | 533 | 1,011 | 15 |
| 31 Dec 15 | 4,176 | 495 | 1,048 | 15 |
| 30 Sep 15 | 4,203 | 428 | 1,034 | 14 |
| 30 Jun 15 | 4,139 | 467 | 1,020 | 14 |
| 31 Mar 15 | 4,010 | 420 | 1,001 | 12 |
| 31 Dec 14 | 3,822 | 381 | 990 | 12 |
| 30 Sep 14 | 3,780 | 374 | 1,004 | 12 |
| 30 Jun 14 | 3,770 | 356 | 1,016 | 13 |
| 31 Mar 14 | 3,859 | 352 | 1,035 | 14 |
| 31 Dec 13 | 3,950 | 415 | 1,033 | 14 |
Quality Earnings: SDF1 has a large one-off loss of €15.8M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: SDF1's current net profit margins (0.7%) are lower than last year (16.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SDF1's earnings have grown significantly by 26.5% per year over the past 5 years.
Accelerating Growth: SDF1's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SDF1 had negative earnings growth (-96.4%) over the past year, making it difficult to compare to the Chemicals industry average (7.2%).
Return on Equity
High ROE: SDF1's Return on Equity (0.4%) is considered low.